SELLAS Life Sciences Group Inc. Common Stock vs Virtu Financial Inc. Class A Common Stock — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.27 (market cap $2.28B), while Virtu Financial Inc. Class A Common Stock trades at $57.56 (market cap $5.19B). The key difference: Virtu Financial Inc. Class A Common Stock is far larger — about 2.3× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Virtu Financial Inc. Class A Common Stock pays a 1.63% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| SLS | VIRT | |
|---|---|---|
Market Cap | $2.28B | $5.19B |
Volume | 3,128,960 | 1,186,043 |
Sector | Health | Financials |
52-Week High | $15.46 | $67.93 |
52-Week Low | $1.39 | $32.53 |
Enterprise Value | $2.15B | $14.90B |
Typical Hold Time | — | 0 Days |
Dividend Yield | — | 1.63% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →Virtu Financial provides technology-enabled market-making and execution services. Its platforms help institutional, retail, and other market participants trade across global financial markets.
Read more on VIRT →